U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758751) titled 'Multisensory 40-Hz Stimulation for Alzheimer's Disease' on Aug. 06.
Brief Summary: This study aims to evaluate the safety and preliminary efficacy of combined auditory and visual 40-Hz stimulation in participants with biomarker-confirmed Alzheimer's disease spectrum disorders. A total of 60 participants with mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia will be randomly assigned in a 1:1 ratio to receive either active multisensory 40-Hz stimulation or sham stimulation. The intervention will be administered for 60 minutes once daily for 4 consecutive weeks. Clinical assessments, electroence...